Shuttle Pharmaceuticals Holdings (SHPH) Cash & Equivalents (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Cash & Equivalents of $1.1 million for Q1 2026, down 76.44% year-over-year from $4.5 million in Q1 2025, and up 312.0% quarter-over-quarter from $257955.0 in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Cash & Equivalents (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Cash & Equivalents history runs 6 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- In Q1 2026, Cash & Equivalents fell 76.44% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (down 76.44% YoY), while the FY2025 annual figure was $257955.0, down 86.57% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $1.1 million, up from $257955.0 in the prior quarter.
- The five-year high for Cash & Equivalents was $9.1 million in Q3 2022, with the low at $156656.0 in Q3 2024.
- The 5-year median for Cash & Equivalents is $2.6 million (2023), against an average of $3.2 million.
- The sharpest annual moves came in 2022 and 2024: Cash & Equivalents jumped 6191.01% in 2022, then plunged 94.54% in 2024.
- Shuttle Pharmaceuticals Holdings' Cash & Equivalents stood at $5.4 million in 2022, then plunged by 52.39% to $2.6 million in 2023, then dropped by 25.47% to $1.9 million in 2024, then tumbled by 86.57% to $257955.0 in 2025, then jumped by 312.0% to $1.1 million in 2026.
- Business Quant data shows SHPH's Cash & Equivalents at $1.1 million in Q1 2026, $257955.0 in Q4 2025, and $2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 164.00 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 1.89 Mn | 1.89 Mn | - | 1.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.06 Mn |
| Dec 31, 2025 | 257,955.00 |
| Sep 30, 2025 | 2.09 Mn |
| Jun 30, 2025 | 4.74 Mn |
| Mar 31, 2025 | 4.51 Mn |
| Dec 31, 2024 | 1.92 Mn |
| Sep 30, 2024 | 156,656.00 |
| Jun 30, 2024 | 645,594.00 |
| Mar 31, 2024 | 364,069.00 |
| Dec 31, 2023 | 2.58 Mn |
| Sep 30, 2023 | 2.87 Mn |
| Jun 30, 2023 | 5.45 Mn |
| Mar 31, 2023 | 6.11 Mn |
| Dec 31, 2022 | 5.41 Mn |
| Sep 30, 2022 | 9.12 Mn |
| Dec 31, 2021 | 504,749.00 |
| Sep 30, 2021 | 144,975.00 |